Patents by Inventor Magnus C. Eriksson

Magnus C. Eriksson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR PREPARATION OF SUBSTITUTED P-AMINOPHENOL
    Publication number: 20130310597
    Abstract: The present invention is related to a process of preparing substituted p-aminophenol compound of formula (I) or a salt thereof,
    Type: Application
    Filed: July 23, 2013
    Publication date: November 21, 2013
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Carl Alan BUSACCA, Magnus C. ERIKSSON, Jinghua XU, Xingzhong Zeng
  • Process for preparation of substituted P-aminophenol
    Patent number: 8519176
    Abstract: The present invention is related to a process of preparing substituted p-aminophenol compound of formula (I) or a salt thereof,
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: August 27, 2013
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Carl A. Busacca, Magnus C. Eriksson, Jinghua Xu, Xingzhong Zeng
  • Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors
    Patent number: 6759533
    Abstract: A process and novel intermediates for making compounds of the formula I: wherein: R2 is selected from the group consisting of H, F, Cl, C1-4 alkyl, C3-4 cycloalkyl and CF3; R4 is H or Me; R5 is H, Me or Et, with the proviso that R4 and R5 are not both Me, and if R4 is Me then R5 cannot be Et; R11 is Me, Et, cyclopropyl, propyl, isopropyl, or cyclobutyl; and Q is selected from the group consisting of:
    Type: Grant
    Filed: June 19, 2003
    Date of Patent: July 6, 2004
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Carl A. Busacca, Magnus C. Eriksson, Ji-Young Kim
  • Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors
    Publication number: 20040002489
    Abstract: A process and novel intermediates for making compounds of the formula I: 1
    Type: Application
    Filed: June 19, 2003
    Publication date: January 1, 2004
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Carl A. Busacca, Magnus C. Eriksson, Ji-Young Kim